Pioneering Deep Health

Building the Metabolomic Digital Twin for Precision Medicine, defining health and disease with Metabolomics and Artificial Intelligence at disruptive scalability and cost!

Latest Announcements:

health 2.0 Conference

3rd - 5th December 2024, Rethinking The Healthcare Landscape

Precision Med Exhibition & Summit

18th - 19thSeptember 2024, Knowledge and clinical application in precision medicine

MedTech Malta

6th - 8th September 2024, MedTech Innovation

A Next-Generation Platform for Affordable Precision Medicine

We have standardized the metabolomic baseline for human health and can detect distinct deviations caused by diseases.*

Cyber-physical system:

From analog blood samples to digital blood samples for health tests

Advanced detection:

Utilization of NMR and AI to capture hundreds of metabolites representing an individual’s health status.

AI and data science:

A system with 240,000+ human datasets for age, sex-specific health baselines, and 700+ diseases, continuously improving itself.

Cloud based:

lifespin’s algorithms and health assessment products are cloud-based and can be used globally based.

In-silico diagnostics:

Development of a “Digital Twin” for personalized health assessment in-silico diagnostics through medical algorithms utilizing the lifespin database

Browse our technology

lifespin has developed a unique method to create a digital snapshot of metabolism. Using NMR technology and proprietary algorithms, we capture quantitatively hundreds of metabolomic parameters with high precision and detect diseases within minutes.

Proactive

Health status identification

Low volume

Test (e.g. 0.5 mL blood)

Lower cost

Per sample than legacy methods

Fast

30 min sample-to-result

Automated

more than 200 samples per day and instrument

Scalable

Connect to every lab with our health assessment Software-as-a-Service

Expert Testimonials

Praise for Our Excellence
“Nearly all diseases are linked to metabolism, which makes lifespin’s technology so powerful.”
Nobel Laureate
Prof. Dr. James Rothman
Sterling Professor of Cell Biology,
Yale University, Physiology/Medicine
Diseases
0 +
Human Profiles
0 +
Healthy Profiles
0 +
Disease Profiles
0 +

A deep data company to map human health and building an innovative health diagnostic testing platform based on metabolomics

Diseases impact metabolism, leading to distinct deviations from the healthy metabolic baseline. All datapoints measured are consistent and can be set in relation to one another. This creates a huge multidimensional space accessible to our AI engine.

To date, we have digitally captured the metabolomes of more than 240,000+ individuals, annotated these with metadata and stored them in our proprietary database. This has allowed us to define the metabolic baseline for human health based on age and gender and are able to detect 700+ diseases in a matter of minutes.

*Disclaimer: lifespin’s products are for Research Use Only (RUO) and currently are not for use in diagnostic procedures. lifespin Products have not been evaluated or approved by the FDA or any other regulatory authority. None of these statements have been endorsed by the FDA or any other regulatory authority. None of the products discussed in this material are currently being sold or offered for sale.

Who we are

lifespin is a pioneering, cross-disciplinary technology company merging NMR, metabolomic and AI to enable a new paradigm of healthcare that is personalized and equitable.

Our AI-driven metabolomics platform provides healthcare professionals with a scalable and sustainable way to deliver affordable precision healthcare utilizing the data captured by digital twinning from blood samples.

Our Mission

To drive a deep health approach to global healthcare by creating digital twins based on metabolomic profiles for proactive, precise, continuous health insights.

Why choose lifespin®

The right treatment sooner based on health data insights

Traditional assessment

Misses cause of unspecific symptoms.

Symptoms are often unspecific in a multitude of diseases

Weeks to years for full diagnosis

Diagnostics cost up to several thousands of EUROs for newly diagnosed patients.

lifespin assessment

Comprehensive and hypothesis-free check for a multitude of states

Digitization of metabolomes enables better and faster diagnosis.

30 min for lifespin diagnostics

Automated, scalable, and lower cost than legacy methods

lifespin® workflow

Transforming the analog blood sample into a digital format for in-silico diagnostics

Team with industry leading expertise

Excellence in science, technology and business

Dr. Ali Tinazli

CEO
15+ years in Fortune 100 corporate strategy and entrepreneurship (SONY, HP).

Dr. Fritz Huber

CEO & Co-Founder
20+ years developing and marketing NMR-based assays—he is a pioneer in this field.

Dr. Renate Kirchhöfer

CDO & Co-Founder
20+ years developing NMR-applications and bringing them to regulated markets.

Dr. Roland Geyer

COO
10+ years experience in NMR-based metabolomics and diagnostic.

Inside lifespin®

Here’s what’s happening
Scroll to Top

Dr. Roland Geyer

COO
10+ years experience in NMR-based metabolomics and diagnostic.

Dr. Renate Kirchhöfer

CDO & Co-Founder
20+ years developing NMR-applications and bringing them to regulated markets.

Dr. Fritz Huber

CEO & Co-Founder
20+ years developing and marketing NMR-based assays—he is a pioneer in this field.

Dr. Ali Tinazli

CEO, lifespin GmbH

15+ years in Fortune 100 corporate strategy and entrepreneurship (SONY, HP).